Background: High levels of lipoprotein(a) [Lp(a)] have been linked to an increased risk of ischaemic cardiovascular events. We examined whether Lp(a) plasma levels are associated with early arteriosclerosis by measuring intima media thickness in an asymptomatic population of Burgos, Spain.
Methods: We determined lipids, lipoprotein(a) by a nephelometry method and the intima-media thickness (IMT) in the far wall of both common carotid arteries by B-mode ultrasound in a group of 172 asymptomatic subjects.
Results: No association was found in the population group between Lp(a) concentrations and left, right, or overall mean IMT by univariate or multivariate regression analysis. The median IMT was not significantly different in individuals with Lp(a) levels >300 mg/l and in individuals with Lp(a) levels <300 mg/l.
Conclusions: These results suggest that increased Lp(a) levels do not confer cardiovascular risk by promoting early atherogenesis, but rather increasing the susceptibility to thrombosis.
TouboulPJLabreucheJVicautEAmarencoP. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke2005; 36(8): 1741–1745.
2.
MasouraCPitsavosCAznaouridisKSkoumasIVlachopoulosCStefanadisC. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis2011; 214(1): 129–138.
3.
Van den BergEBiesselsGJStehouwerCDKappelleLJHeineRJNijpelsG. Ten-year time course of risk factors for increased carotid intima-media thickness: the Hoorn Study. Eur J Cardiovasc Prev Rehabil2010; 17(2): 168–174.
4.
RasouliMLNasirKBlumenthalRSParkRAzizDCBudoffMJ. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis2005; 181(1): 159–165.
5.
McLeanJWTomlinsonJEKuangWJEatonDLChenEYFlessGM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature1987; 330(6144): 132–137.
MarcovinaSMAlbersJJJacobsDRJrPerkinsLLLewisCEHowardBV. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb1993; 13(7): 1037–1045.
8.
MilesLAFlessGMScanuAMBaynhamPSebaldMTSkocirP. Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost1995; 73(3): 458–465.
9.
KirschenlohrHLMetcalfeJCWeissbergPLGraingerDJ. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. Cardiovasc Res1995; 29(6): 848–855.
10.
BergK. A new serum type system in man- the Lp system. Acta Pathol Microbiol Scand1963; 59: 369–382.
11.
Sociedad Española de Bioquímica Clínica y Patología Molecular. Comisión de Lípidos y Lipoproteínas. Protocolo para la obtención de especimenes en las determinaciones de lípidos y lipoproteínas. Quím Clin1989; 8(5): 349–361.
12.
MarcovinaSMAlbersJJScanuAMKennedyHGiaculliFCoudercR. Use of a reference material proposed by The International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem2000; 46(12): 1956–1967.
13.
DahlenGHGuytonJRAttarMFarmerJAKautzJAGottoAMJr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation1986; 74(4): 758–765.
14.
RosengrenAWilhelmsenLErikssonERisbergBWedelH. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ1990; 301(6763): 1248–1251.
15.
ArmstrongVWCremerPEberleEMankeASchulzeFWielandH. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis1986; 62(3): 249–257.
BaldassarreDTremoliEFranceschiniGMichelagnoliSSirtoriCR. Plasma lipoprotein (a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke1996; 27(6): 1044–1049.
18.
FadiniGPCoracinaAInchiostroSTiengoAAvogaroAde KreutzenbergSV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil2008; 15(2): 190–196.
19.
De MicheleMIannuzziAPanicoSCelentanoESacchettiLMazzaccaraC. Effect of high-density lipoprotein cholesterol levels on carotid artery geometry in a Mediterranean female population. Eur J Cardiovasc Prev Rehabil2004; 11(5): 403–407.
20.
SrámekAReiberJHBaak-PabloRSturkARosendaalFR. Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery. J Thromb Haemost2003; 1(2): 374–379.
21.
DentiLMarchiniLPasoliniGBaffoniMTAblondiFValentiG. Lipoprotein Lp(a) and cerebrovascular disease in the elderly: correlations with the severity of extracranial carotid atherosclerosis assessed by ultrasonography. Acta Biomed Ateneo Parmense1995; 66(3–4): 175–183.
22.
GrebeMTSchoeneESchaeferCABoedekerRHKemkes-MatthesBVossR. Elevated Lipoprotein (a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis2007; 190(1): 194–198.
23.
El-GendiSSBakeetMYEl-HamedEAIbrahimFKAhmedR. The value of lipoprotein (a), homocysteine, and Doppler of carotid and femoral arteries in assessment of atherosclerosis in asymptomatic cardiovascular risk patients. J Cardiol2008; 52(3): 202–211.
24.
LinnebankMMoskauSFarmandSFliessbachKKölschHBösM. Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance. Stroke2006; 37(11): 2840–2842.
25.
JonesDWChamblessLEFolsomARHeissGHutchinsonRGSharrettAR. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987–1997. Arch Intern Med2002; 162(22): 2565–2571.
26.
SchreinerPJHeissGTyrolerHAMorrisettJDDavisCESmithR. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol1996; 16(3): 471–478.
27.
Emerging risk factors collaboration, ErqouSKaptogeSPerryPLDi AngelantonioEThompsonAWhiteIR. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA2009; 302(4): 412–423.
28.
CalmarzaPCorderoJSantosVVellaJC. Apolipoprotein(a) isoforms in infarcted men under 60 years old. Clin Biochem2004; 37(10): 911–918.
29.
KamstrupPRTybjaerg-HansenASteffensenRNordestgaardBG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA2009; 301(22): 2331–2339.
30.
LiuLCraigAWMeldrumHDMarcovinaSMElliottBEKoschinskyML. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3. Biochem J2009; 418(2): 325–336.
31.
ChoTJungYKoschinskyML. Apolipoprotein(a), through its strong lysine-binding site in KIV10, mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway. J Biol Chem2008; 283(45): 30503–30512.
32.
FraleyAESchwartzGGOlssonAGKinlaySSzarekMRifaiN. MIRACL Study Investigators. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol2009; 53(23): 2186–2196.
